Metoprolol Succinate Extended Release



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 45.8%
Cardiovascular Event Prophylaxis 8.5%
Blood Pressure 5.2%
Coronary Artery Disease 4.6%
Palpitations 4.6%
Anxiety 3.9%
Atrial Fibrillation 3.9%
Depression 3.9%
Tachycardia 3.9%
Cardiac Disorder 2.6%
Arrhythmia 1.3%
Blood Cholesterol Abnormal 1.3%
Blood Pressure Increased 1.3%
Cardiac Failure Congestive 1.3%
Heart Rate Abnormal 1.3%
Heart Rate Increased 1.3%
Heart Rate Irregular 1.3%
Hepatitis C 1.3%
Insomnia 1.3%
Migraine 1.3%
Product Quality Issue 16.0%
Pharmaceutical Product Complaint 15.0%
Therapeutic Response Unexpected With Drug Substitution 14.0%
Product Substitution Issue 10.0%
Palpitations 6.0%
Weight Increased 5.0%
Vision Blurred 4.0%
Vomiting 4.0%
Blood Pressure Increased 3.0%
Syncope 3.0%
Concomitant Disease Progression 2.0%
Feeling Abnormal 2.0%
Heart Rate Increased 2.0%
Malaise 2.0%
Oedema Peripheral 2.0%
Rash 2.0%
Supraventricular Tachycardia 2.0%
Tachycardia 2.0%
Tremor 2.0%
Ventricular Extrasystoles 2.0%
Secondary
Product Used For Unknown Indication 58.7%
Hypertension 6.5%
Anxiety 5.1%
Cardiovascular Event Prophylaxis 4.3%
Cardiac Disorder 2.9%
Depression 2.9%
Palpitations 2.9%
Atrial Fibrillation 2.2%
Blood Pressure Abnormal 2.2%
Cerebrovascular Accident Prophylaxis 2.2%
Cardiac Failure 1.4%
Coronary Artery Disease 1.4%
Insomnia 1.4%
Ventricular Hypokinesia 1.4%
Abdominal Pain Upper 0.7%
Angina Pectoris 0.7%
Arrhythmia 0.7%
Blood Cholesterol 0.7%
Blood Cholesterol Abnormal 0.7%
Blood Cholesterol Increased 0.7%
Poisoning 17.1%
Completed Suicide 11.4%
Accidental Exposure 5.7%
Dyspnoea 5.7%
Medication Error 5.7%
Palpitations 5.7%
Sinus Bradycardia 5.7%
Vomiting 5.7%
Wrong Drug Administered 5.7%
Blood Chloride Decreased 2.9%
Blood Pressure Inadequately Controlled 2.9%
Cardiac Arrest 2.9%
Death 2.9%
Gastrointestinal Haemorrhage 2.9%
Headache 2.9%
Insomnia 2.9%
Myocardial Infarction 2.9%
Off Label Use 2.9%
Overdose 2.9%
Pharyngeal Oedema 2.9%
Concomitant
Hypertension 14.3%
Atrial Fibrillation 13.5%
Product Used For Unknown Indication 13.0%
Drug Use For Unknown Indication 11.8%
Pain 8.3%
Prophylaxis 4.3%
Diabetes Mellitus 3.3%
Blood Cholesterol Increased 3.1%
Diffuse Large B-cell Lymphoma 2.9%
Blood Pressure 2.7%
Hypothyroidism 2.7%
Supplementation Therapy 2.7%
Convulsion 2.5%
Gastrooesophageal Reflux Disease 2.5%
Rheumatoid Arthritis 2.5%
Cardiovascular Event Prophylaxis 2.1%
Anticoagulant Therapy 1.9%
Arrhythmia 1.9%
Asthma 1.9%
Chronic Obstructive Pulmonary Disease 1.9%
Vomiting 18.2%
Weight Decreased 12.5%
Weight Increased 9.1%
Rash 4.5%
Tinnitus 4.5%
Urinary Tract Infection 4.5%
Visual Acuity Reduced 4.5%
Abdominal Pain 3.4%
Atrial Flutter 3.4%
Decreased Appetite 3.4%
Dizziness 3.4%
Drug Exposure During Pregnancy 3.4%
Dysgeusia 3.4%
Fatigue 3.4%
Gastrointestinal Haemorrhage 3.4%
Nausea 3.4%
Skin Warm 3.4%
Urticaria 3.4%
Death 2.3%
Depression 2.3%